Platelet dysfunction in patients with traumatic intracranial hemorrhage: Do desmopressin and platelet therapy help or harm? - 15/12/21
, Julia Riccardi a, c
, Helen Horng b
, Gregory Kacprzynski a, d
, Ziad Sifri a 
Abstract |
Background |
Pre-injury anti-platelet use has been associated with increased risk of progression of traumatic intracranial hemorrhage (TICH) and worse outcomes. VerifyNow® assays assess platelet inhibition due to aspirin/clopidogrel. This study assesses the outcomes of patients with TICH and platelet dysfunction treated with desmopressin and/or platelets.
Methods |
We performed a retrospective chart review of patients with mild TICH at a level 1 trauma center 1/1/2013–6/1/2016. Patients with documented platelet dysfunction who received desmopressin and/or platelets were compared to those who were untreated. Primary outcomes were progression of TICH and neurologic outcomes at discharge.
Results |
Of 565 patients with a mild TICH, 200 patients had evidence of platelet dysfunction (a positive VerifyNow® assay). Patients had similar baseline demographics, injury characteristics, and rate of TICH progression; but patients who received desmopressin and/or platelets had worse Glasgow Outcomes Score at discharge.
Conclusion |
Treatment of patients with mild TICH and platelet dysfunction with desmopressin and/or platelets did not affect TICH progression but correlated with worse neurologic status at discharge.
Il testo completo di questo articolo è disponibile in PDF.Graphical abstract |
Highlights |
• | Traumatic brain injury patients may have worse outcomes if on antiplatelet therapy. |
• | Treating these patients with desmopressin and/or platelets may not improve outcomes. |
• | Further studies to investigate optimal treatment strategies for these patients are warranted. |
Keywords : Traumatic brain injury, Antiplatelet therapy, Outcomes research
Mappa
| ☆ | This study was presented at the 33rd Eastern Association for the Surgery of Trauma Annual Assembly in January 2020 in Orlando, FL. |
Vol 223 - N° 1
P. 131-136 - gennaio 2022 Ritorno al numeroBenvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
Già abbonato a @@106933@@ rivista ?
